<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02392403</url>
  </required_header>
  <id_info>
    <org_study_id>CLTD5446</org_study_id>
    <nct_id>NCT02392403</nct_id>
  </id_info>
  <brief_title>Clinical Investigation of the Nucleus® CI532 Cochlear Implant</brief_title>
  <official_title>Clinical Investigation of the Nucleus® CI532 Cochlear Implant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cochlear</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cochlear</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the clinical benefit for patients implanted with the
      Nucleus® CI532 cochlear implant and to demonstrate the atraumatic nature of the electrode
      design.

      Nucleus® CI532 has a pre-curved, perimodiolar array, the EA32, which is introduced into the
      cochlea through a straightening sheath.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Scalar Position of Electrode Array Determined With Computer Tomography (CT) Scan</measure>
    <time_frame>up to one month post-surgery</time_frame>
    <description>The position of the electrode array can be completely in scala tympani, completely in scala vestibuli, or may transverse from scala tympani to scala vestibuli. The position can be determined from high resolution flat panel volume tomography (Cone beam) imaging.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Array Proximity to the Modiolus Measured Using the Wrapping Factor</measure>
    <time_frame>up to one month post-surgery</time_frame>
    <description>The ratio of the active array length and the corresponding lateral wall length</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgeon Questionnaire on Implant Surgery</measure>
    <time_frame>at time of surgery</time_frame>
    <description>To collect experiences using the CI532. At each surgery, the surgeon was asked whether &quot;overall the CI532 was easy to handle and the EA32 easy to insert&quot;. We counted the number of surgeons who strongly agreed or who agreed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Speech Recognition in Quiet and Noise at 6 Months</measure>
    <time_frame>baseline and 6 months post activation</time_frame>
    <description>Change in percent correct speech recognition test scores for implant ear alone and best aided</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Benefit in Health Status Assessed Via Glasgow Benefit Inventory Questionnaire</measure>
    <time_frame>6 months post activation</time_frame>
    <description>The Glasgow Benefit Inventory is a single time point measure of patient reported benefit.
A score of 0 indicates no benefit; the minimum score is -100 and the maximum is +100.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Hearing Ability Assessed Via Speech Spatial Hearing Qualities Questionnaire at 6 Months</measure>
    <time_frame>baseline and 6 months post activation</time_frame>
    <description>Rating scale. 0=worst; 10=best</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Air-conduction Pure-tone Hearing Thresholds Via an Audiogram at 6 Months</measure>
    <time_frame>baseline and 6 months post activation</time_frame>
    <description>We report only the change for the 500 Hz frequency.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Adverse Events at Surgery</measure>
    <time_frame>at time of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Adverse Events Post Surgery to 6 Months Post-activation</measure>
    <time_frame>post surgery to 6 months post-activation</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Hearing Loss</condition>
  <arm_group>
    <arm_group_label>Nucleus CI532 cochlear implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nucleus CI532 cochlear implant</intervention_name>
    <arm_group_label>Nucleus CI532 cochlear implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eighteen years of age or older at the time of implantation

          -  Conventional candidate for cochlear implantation with a perimodiolar electrode array
             according to local criteria (excepting the exclusion criteria that follow)

          -  Native speaker in the local language used to assess clinical performance

        Exclusion Criteria:

          -  Evidence of hearing loss prior to 5 years of age

          -  Prior cochlear implantation; i.e. having a cochlear implant in the contralateral ear,
             or previously implanted in either ear

          -  Medical or psychological conditions that contraindicate undergoing general anaesthesia
             or surgery

          -  Ossification, malformation or any other cochlear anomaly, such as common cavity, that
             might prevent complete insertion of the electrode array, as confirmed by medical
             examination

          -  Hearing impairment due to lesion or neuropathy of the acoustic nerve, VIII nerve or
             central auditory pathway

          -  Active middle-ear infection

          -  Tympanic membrane perforation

          -  Unrealistic expectations on the part of the subject, regarding the possible benefits,
             risks, and limitations that are inherent to the surgical procedure(s) and prosthetic
             devices

          -  Unwillingness or inability of the candidate to comply with all investigational
             requirements such as undergoing a post-operative digital volume tomography/ConeBeam
             scan

          -  Patients with existing Cerebral Spinal Fluid shunts or drains, existing perilymph
             fistula, skull fracture or Cerebral Spinal Fluid leak

          -  Patients with recurrent episodes of bacterial meningitis

          -  Pregnancy or breast-feeding

          -  Known allergies to components of the implant

          -  Wearing other active implants with known interference with cochlear implants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chris J James, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Cochlear</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The HEARing CRC</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3010</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service d' ORL et d'Otoneurochirurgie, CHU Toulouse Purpan</name>
      <address>
        <city>Toulouse</city>
        <state>Midi-Pyrénées</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ear, Nose and Throat Department, University of Freiburg</name>
      <address>
        <city>Freiburg</city>
        <state>Baden-Württemberg</state>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ear, Nose and Throat Department, Universitätsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <state>Bavaria</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der J. W. Goethe-Universität Frankfurt</name>
      <address>
        <city>Frankfurt am Main</city>
        <state>Hessen</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ear, Nose and Throat Department, Medizinische Hochschule</name>
      <address>
        <city>Hannover</city>
        <state>Niedersachsen</state>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein - Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <state>Schleswig-Holstein</state>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario Insular Materno Infantil</name>
      <address>
        <city>Las Palmas</city>
        <state>Gran Canaria</state>
        <zip>35016</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <study_first_submitted>March 13, 2015</study_first_submitted>
  <study_first_submitted_qc>March 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2015</study_first_posted>
  <results_first_submitted>July 27, 2017</results_first_submitted>
  <results_first_submitted_qc>February 26, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">November 1, 2018</results_first_posted>
  <last_update_submitted>February 26, 2018</last_update_submitted>
  <last_update_submitted_qc>February 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Nucleus CI532 Cochlear Implant</title>
          <description>Single arm study. All participants received CI532.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Nucleus CI532 Cochlear Implant</title>
          <description>Single arm study. All participants received CI532.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="45"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61" spread="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Scalar Position of Electrode Array Determined With Computer Tomography (CT) Scan</title>
        <description>The position of the electrode array can be completely in scala tympani, completely in scala vestibuli, or may transverse from scala tympani to scala vestibuli. The position can be determined from high resolution flat panel volume tomography (Cone beam) imaging.</description>
        <time_frame>up to one month post-surgery</time_frame>
        <population>One patient was explanted and reimplanted with a different type of device.</population>
        <group_list>
          <group group_id="O1">
            <title>Nucleus CI532 Cochlear Implant</title>
            <description>Single arm study. All participants received CI532.</description>
          </group>
        </group_list>
        <measure>
          <title>Scalar Position of Electrode Array Determined With Computer Tomography (CT) Scan</title>
          <description>The position of the electrode array can be completely in scala tympani, completely in scala vestibuli, or may transverse from scala tympani to scala vestibuli. The position can be determined from high resolution flat panel volume tomography (Cone beam) imaging.</description>
          <population>One patient was explanted and reimplanted with a different type of device.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Completely in scala tympani</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dislocation in scala vestibuli</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Array Proximity to the Modiolus Measured Using the Wrapping Factor</title>
        <description>The ratio of the active array length and the corresponding lateral wall length</description>
        <time_frame>up to one month post-surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nucleus CI532 Cochlear Implant</title>
            <description>Single arm study. All participants received CI532.</description>
          </group>
        </group_list>
        <measure>
          <title>Array Proximity to the Modiolus Measured Using the Wrapping Factor</title>
          <description>The ratio of the active array length and the corresponding lateral wall length</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.62" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Surgeon Questionnaire on Implant Surgery</title>
        <description>To collect experiences using the CI532. At each surgery, the surgeon was asked whether &quot;overall the CI532 was easy to handle and the EA32 easy to insert&quot;. We counted the number of surgeons who strongly agreed or who agreed.</description>
        <time_frame>at time of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nucleus CI532 Cochlear Implant</title>
            <description>Single arm study. All participants received CI532.</description>
          </group>
        </group_list>
        <measure>
          <title>Surgeon Questionnaire on Implant Surgery</title>
          <description>To collect experiences using the CI532. At each surgery, the surgeon was asked whether &quot;overall the CI532 was easy to handle and the EA32 easy to insert&quot;. We counted the number of surgeons who strongly agreed or who agreed.</description>
          <units>Surgeons</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Speech Recognition in Quiet and Noise at 6 Months</title>
        <description>Change in percent correct speech recognition test scores for implant ear alone and best aided</description>
        <time_frame>baseline and 6 months post activation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nucleus CI532 Cochlear Implant</title>
            <description>Single arm study. All participants received CI532.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Speech Recognition in Quiet and Noise at 6 Months</title>
          <description>Change in percent correct speech recognition test scores for implant ear alone and best aided</description>
          <units>Percent correct</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Quiet Implant Ear</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.500" lower_limit="25.0" upper_limit="71.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quiet Best Aided</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.668" lower_limit="12.5" upper_limit="56.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 db Signal-to-Noise Ratio (SNR) Implant Ear</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.725" lower_limit="5.6" upper_limit="88.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 db Signal-to-Noise Ratio (SNR) Best Aided</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.690" lower_limit="2.5" upper_limit="63.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reported Benefit in Health Status Assessed Via Glasgow Benefit Inventory Questionnaire</title>
        <description>The Glasgow Benefit Inventory is a single time point measure of patient reported benefit.
A score of 0 indicates no benefit; the minimum score is -100 and the maximum is +100.</description>
        <time_frame>6 months post activation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nucleus CI532 Cochlear Implant</title>
            <description>Single arm study. All participants received CI532.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reported Benefit in Health Status Assessed Via Glasgow Benefit Inventory Questionnaire</title>
          <description>The Glasgow Benefit Inventory is a single time point measure of patient reported benefit.
A score of 0 indicates no benefit; the minimum score is -100 and the maximum is +100.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.1" lower_limit="21.577" upper_limit="34.738"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Hearing Ability Assessed Via Speech Spatial Hearing Qualities Questionnaire at 6 Months</title>
        <description>Rating scale. 0=worst; 10=best</description>
        <time_frame>baseline and 6 months post activation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nucleus CI532 Cochlear Implant</title>
            <description>Single arm study. All participants received CI532.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Hearing Ability Assessed Via Speech Spatial Hearing Qualities Questionnaire at 6 Months</title>
          <description>Rating scale. 0=worst; 10=best</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.22" lower_limit="1.695" upper_limit="2.750"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Air-conduction Pure-tone Hearing Thresholds Via an Audiogram at 6 Months</title>
        <description>We report only the change for the 500 Hz frequency.</description>
        <time_frame>baseline and 6 months post activation</time_frame>
        <population>Note that some patients had no measurable pre-operative hearing</population>
        <group_list>
          <group group_id="O1">
            <title>Nucleus CI532 Cochlear Implant</title>
            <description>Single arm study. All participants received CI532.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Air-conduction Pure-tone Hearing Thresholds Via an Audiogram at 6 Months</title>
          <description>We report only the change for the 500 Hz frequency.</description>
          <population>Note that some patients had no measurable pre-operative hearing</population>
          <units>Decibels</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="5" upper_limit="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Adverse Events at Surgery</title>
        <time_frame>at time of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nucleus CI532 Cochlear Implant</title>
            <description>Single arm study. All participants received CI532.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Adverse Events at Surgery</title>
          <units>adverse events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Adverse Events Post Surgery to 6 Months Post-activation</title>
        <time_frame>post surgery to 6 months post-activation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nucleus CI532 Cochlear Implant</title>
            <description>Single arm study. All participants received CI532.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Adverse Events Post Surgery to 6 Months Post-activation</title>
          <units>adverse events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>16 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Nucleus CI532 Cochlear Implant</title>
          <description>Single arm study. All participants received CI532.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="45"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Death due to myocardial infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Prolonged hospitalization for re-implantation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization for hysterectomy and bladder wall reinforcement</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="45"/>
              </event>
              <event>
                <sub_title>Dizziness and/or vertigo</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The investigator agrees to send any Conference presentations/publications to the Sponsor for review at least 30 days prior to publication/presentation and after the first publication has been submitted. The Sponsor has the right to require any confidential information to be removed. If there is intellectual property disclosed, which the Sponsor intends to protect by registration such as by patent application, the Sponsor may require the release of the publication to be delayed by up to 120 days.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Chris James</name_or_title>
      <organization>Cochlear</organization>
      <phone>+33 534 638 584</phone>
      <email>cjames@cochlear.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

